{"id":"W2557113503","doi":"10.1182/blood.v122.21.4400.4400","title":"Final Results Of a Phase I Study Of The Anti-CD79b Antibody-Drug Conjugate DCDS4501A In Relapsed Or Refractory (R/R) B-Cell Non-Hodgkin Lymphoma (NHL)","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Alberta; BC Cancer Agency; Jewish General Hospital","funders":"","keywords":"Tolerability; Medicine; Neutropenia; Internal medicine; Gastroenterology; Adverse effect; Rituximab; Anemia; Hypokalemia; Fludarabine; Surgery; Toxicity; Lymphoma; Chemotherapy; Cyclophosphamide","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001178285,0.0006403945,0.0009754322,0.0001715974,0.0002720604,0.0006701585,0.0004208868,0.0004284765,0.001681934],"category_scores_gemma":[0.000674176,0.0002161987,0.000740082,0.000186716,0.0003690659,0.0003119109,0.0002191289,0.001095159,0.000528114],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004819037,"about_ca_system_score_gemma":0.0005505568,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008176118,"about_ca_topic_score_gemma":0.001213961,"domain_scores_codex":[0.9996449,0.0001601769,0.00002534425,0.00005489901,0.00004147593,0.00007324347],"domain_scores_gemma":[0.999535,0.00008977545,0.00007023289,0.00005196845,0.00004971199,0.0002034771],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.2602997,0.05242962,0.05267409,0.0009544145,0.002368606,0.001552447,0.0008086588,0.006227682,0.3815733,0.0003030444,0.007417983,0.2333905],"study_design_scores_gemma":[0.08417367,0.7331815,0.1029481,0.0000467717,0.001897317,0.002039806,0.0001757908,0.002497646,0.06181466,0.0003599827,0.0108171,0.000047678],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9950359,0.001115213,0.0007811515,0.0001145268,0.000032464,0.0006845038,0.001086701,0.00005238921,0.001097031],"genre_scores_gemma":[0.9935706,0.0006712695,0.001148333,0.0002380516,0.00004552386,0.0003055932,0.002753808,0.0000255573,0.00124142],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001681934,"threshold_uncertainty_score":0.006231427,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01929168676749963,"score_gpt":0.2922092397343984,"score_spread":0.2729175529668988,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}